Similar Items: White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
- The Indiana University Brain Health Program to deliver amyloid‐targeted therapy to Alzheimer's disease patients
- Association of plasma irisin levels with amyloid burden in the Alzheimer's disease spectrum
- Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
- Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease
- Association of Excessive Daytime Sleepiness With Long‐Term Incident Dementia: The Role of β‐Amyloid and White Matter Injury
- Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection